nitrendipine and cromakalim

nitrendipine has been researched along with cromakalim in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arch, JR; Challiss, RA; Patel, N1
Burden, DT; Burke, YM; Cowlrick, IS; Paciorek, PM; Perkins, RS; Taylor, JC; Waterfall, JF1
Cavero, I; Hyman, A; Le Monnier de Gouville, AC; Lippton, H; Mondot, S1
Coldwell, MC; Howlett, DR1
Falotico, R; Giardino, EC; Katz, LB; Moore, JB; Salata, JJ1

Other Studies

5 other study(ies) available for nitrendipine and cromakalim

ArticleYear
Comparative effects of BRL 38227, nitrendipine and isoprenaline on carbachol- and histamine-stimulated phosphoinositide metabolism in airway smooth muscle.
    British journal of pharmacology, 1992, Volume: 105, Issue:4

    Topics: Animals; Benzopyrans; Carbachol; Cattle; Cromakalim; Histamine; In Vitro Techniques; Isoproterenol; Muscle, Smooth; Nitrendipine; Parasympatholytics; Phosphatidylinositols; Pyrroles; Trachea

1992
Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:2

    Topics: Anesthesia; Animals; Benzopyrans; Blood Pressure; Cardiac Output; Cats; Cromakalim; Female; Heart Rate; Hemodynamics; Male; Nitrendipine; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance

1990
Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 252, Issue:1

    Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Drug Tolerance; Endothelins; Endothelium, Vascular; Hemodynamics; Imidazoles; In Vitro Techniques; Male; Nitrendipine; Peptides; Potassium Channels; Pyrroles; Rats; Rats, Inbred SHR; Tachyphylaxis; Vasoconstriction; Vasodilation; Vasopressins

1990
Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil.
    Biochemical pharmacology, 1987, Nov-01, Volume: 36, Issue:21

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Antihypertensive Agents; Apamin; Benzopyrans; Binding Sites; Cromakalim; Cyclic AMP; Cyclic GMP; Inositol Phosphates; Ion Channels; Male; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nitrendipine; Potassium; Pyrroles; Rats; Rats, Inbred Strains; Rubidium; Tetraethylammonium Compounds

1987
RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

    Topics: Angina Pectoris; Animals; Antihypertensive Agents; Benzopyrans; Bronchoconstriction; Calcium Channel Blockers; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Ferrets; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Macaca mulatta; Male; Mice; Mice, Inbred Strains; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrendipine; Papillary Muscles; Pilocarpine; Potassium Channels; Pyrans; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rubidium; Rubidium Radioisotopes; Thiophenes; Vasodilator Agents

1993